FemCalf: Innovative Feed Supplement for Female Calf Outcomes – Seeking Distributors, Investors and Commercial Partners
Opportunity for
- Commercial partners and investors to expand market presence in Australia, New Zealand, and Asia.
- Distributors with access to livestock, dairy, veterinary and agribusiness sectors.
- Strategic collaborations with livestock and dairy organisations to scale adoption.
- Trial partners for a pilot project to demonstrate impact in Australian and New Zealand markets.
Opportunity description
Industry challenge
Achieving targeted herd composition is critical for dairy and livestock industries worldwide, yet traditional sex-sorted semen technologies have limitations- works mostly in Heifers, including high costs, low conception rates, storage challenges, may result mutations and infertility in mammals. Farmers and producers need a more effective, scalable, and natural solution to influence offspring sex ratios without compromising fertility or animal health.
Current opportunity
FemCalf is a first-of-its-kind ( 300ml ) oral feed supplement that naturally supports “sex fixation” at the time of conception, promoting the birth of female calves in cows and buffaloes. It works across all parities, in both indigenous breeds and advanced cattle species, making it a superior alternative to conventional reproductive technologies. FemCalf also increases lactation cycles and can reduce Artificial Insemination (AI) attempts by over 50%. Product can be effective in Sheep, Goat, Deer, Horse, Yaks and some other mammals – open for scientific discussion and evaluation
Following 15 years of research and extensive trials across Europe, Africa, India, and the UK, the technology has demonstrated strong results in a variety of farming systems. For regulatory purposes this technology is established as a feed supplement rather than a pharmaceutical product, FemCalf is now seeking partners to support its commercial expansion into Australia, New Zealand, and Asia.The opportunity is open to commercial partners, distributors, investors, and industry stakeholders interested in bringing this technology to new markets. Ideal partners would include distributors with established networks in livestock, dairy, veterinary and agribusiness, as well as organisations looking to incorporate innovative reproductive technologies into their existing product portfolios. FemCalf is also seeking investors to support scaling efforts in Australia and New Zealand, helping to establish local operations, expand market reach, and drive adoption. Additionally, there is scope for collaboration with livestock industry bodies, research groups, and commercial enterprises to facilitate adoption through pilot projects and on-farm trials.
To find out more about this opportunity or express your interest in partnering, equire below now.
Opportunity background
FemCalf has received recognition from industry leaders, including ILRI (International Livestock Research Institute), and has been granted patents in Australia, New Zealand, the US, Canada, and South Africa. The product has undergone extensive validation through trials with government bodies, livestock and animal husbandry departments, research institutions, universities, and private enterprises, demonstrating its efficacy and suitability for large-scale commercial use.
As the technology moves into new markets, establishing strong partnerships will be essential to drive adoption, build industry confidence, and support market education. The development of pilot projects in key regions, alongside targeted distribution partnerships, will play a crucial role in positioning Femcalf as a leading solution for livestock reproductive management.
Potential other applications
- Expansion into other livestock species, including sheep, goats, deer, horse, yaks and camels.
- Partnerships with dairy and beef industry bodies to support widespread adoption.
- Development of tailored versions for region-specific livestock systems.